Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ideström

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 1, 1979
Changes of the peripheral lymphocyte population following radiation therapy to extended and limited fieldsK Ideström, B Petrini, H Blomgren, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1980
Lymphocyte counts and responses to PHA and PPD following radiation therapy for breast cancer in patients who develop recurrent disease and those who remain clinically disease-freeH Blomgren, J Wasserman, A Wallgren, et al.
Acta Medica Scandinavica|January 1, 1979
Interferon therapy in multiple myelomaK Ideström, K Cantell, D Killander, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1979
Changes in mixed lymphocyte culture (MLC) functions of peripheral lymphoid cells after radiation therapy for breast carcinomaH Blomgren, J Wasserman, A Wallgren, et al.
European Journal of Haematology|January 1, 1991
Mitoxantrone, etoposide, cytarabine and prednisone as salvage therapy for refractory non-Hodgkin lymphoma (NHL) and alternated with CHOP in previously untreated patients with NHLK Merk, K Ideström, B Johansson, et al.
Acta Radiologica: Oncology, Radiation, Physics, Biology|January 1, 1979
Prognistic relevance of radiation induced immune suppression in breast carcinomaE Baral, H Blomgren, K Ideström, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Second-line endocrine treatment of advanced breast cancer--a randomized cross-over study of medroxy-progesterone acetate and aminoglutethimideR Hultborn, I Johansson-Terje, J Bergh, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1982
Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisoloneK Ideström, E Kimby, M Björkholm, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Radiation Oncology, Biology, Physics|October 1, 1979
Changes of the peripheral lymphocyte population following radiation therapy to extended and limited fieldsK Ideström, B Petrini, H Blomgren, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1980
Lymphocyte counts and responses to PHA and PPD following radiation therapy for breast cancer in patients who develop recurrent disease and those who remain clinically disease-freeH Blomgren, J Wasserman, A Wallgren, et al.
Acta Medica Scandinavica|January 1, 1979
Interferon therapy in multiple myelomaK Ideström, K Cantell, D Killander, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1979
Changes in mixed lymphocyte culture (MLC) functions of peripheral lymphoid cells after radiation therapy for breast carcinomaH Blomgren, J Wasserman, A Wallgren, et al.
European Journal of Haematology|January 1, 1991
Mitoxantrone, etoposide, cytarabine and prednisone as salvage therapy for refractory non-Hodgkin lymphoma (NHL) and alternated with CHOP in previously untreated patients with NHLK Merk, K Ideström, B Johansson, et al.
Acta Radiologica: Oncology, Radiation, Physics, Biology|January 1, 1979
Prognistic relevance of radiation induced immune suppression in breast carcinomaE Baral, H Blomgren, K Ideström, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Second-line endocrine treatment of advanced breast cancer--a randomized cross-over study of medroxy-progesterone acetate and aminoglutethimideR Hultborn, I Johansson-Terje, J Bergh, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1982
Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisoloneK Ideström, E Kimby, M Björkholm, et al.
Pageof 1